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Nur77的二聚化机理，同时也从侧面研究 LBD二聚化在 Nur77与 DNA结合时的
形式和作用。我们克隆并表达了 Nur77 DBD的蛋白，并与 NurRE共同纯化后进
行了晶体生长条件的筛选和优化，最终得到了晶体类似物，为解析 DBD与 NurRE
复合物晶体结构奠定了基础。 



































Nuclear receptor superfamily consists of transcription factors that are 
evolutionarily related and can interact with specific DNA fragments. As a member of 
this super family, orphan nuclear receptor Nur77 participates in regulation of cell 
growth, differentiation and apoptosis under various stimuli and plays an important 
role in development process. In recent years, Nur77 becomes a widely studied 
potential drug target. Under specific stimuli such as binding with the corresponding 
ligand, classic nuclear receptors form homo- or heterodimers mainly by their ligand 
binding domains (LBDs), and interact with specific DNA sequences called response 
element (RE) for their function of transcriptional activation. Nur77 monomers, 
homodimers and heterodimers can combine with different response elements, 
respectively. However, the exact mechanism of the dimerization is yet to be revealed. 
During the analysis of prior study on Nur77 in the LBD high-resolution crystal 
three-dimensional structure, we found a special form of dimerization by H11-H12 
dimeric interface of LBD. This new form of dimerization was different from that of 
classic nuclear receptors dimerization or some nonclassic nuclear receptors reported 
before. Through the software analysis, we believed that this form of dimerization can 
exist stably in solution, but de-dimerization might occer under certain conditions due 
to the small surface area. We further confirmed the above results from small angle X 
ray scattering as well as gel filtration column chromatography experiments, and the 
LBD mutation test showed that the H11-H12 motif was very important for the dimer’s 
maintenance in solution. 
In the second part of the study, we tried to get the complex crystal structure of 
Nur77 DNA binding domain (DBD) dimer and the dimeric response element, NurRE, 
and then showed the dimerization mechanism of Nur77 and its LBD when Nur77 bind 
with DNA. We cloned and expressed Nur77 DBD, and purified the protein with 















crystal analogues, which laid the foundation for the crystal structure of NurRE and 
DBD complex. 
Through revealing a special form of dimerization by Nur77 LBD crystal structure 
and structure research of DBD complex with response element NurRE, we speculated 
that Nur77 had different form of dimerization in vivo. It is significant contribution to 
revealing the mechanism of different functions of nuclear receptors, especially the 
orphan nuclear receptors. 
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